טוען...
How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Clinical Oncology
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2868641/ https://ncbi.nlm.nih.gov/pubmed/20808559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.091092 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|